Endolymphatic hydrops in patients with migraine: a correlative study - Scorecard - MDSpire

Endolymphatic hydrops in patients with migraine: a correlative study

  • By

  • Anne R. J. Péporté

  • Fabian Schön

  • Gustav Andreisek

  • Jatta Berberat

  • Franca Wagner

  • June 26, 2026

  • 0 min

Share

Clinical Scorecard: Correlation Between Endolymphatic Hydrops and Migraine Indicators: An MRI-Based Analysis

At a Glance

CategoryDetail
ConditionEndolymphatic Hydrops
Key MechanismsPathological distension of the membranous labyrinth from excess endolymph.
Target PopulationPatients with confirmed endolymphatic hydrops, average age 53.6 years.
Care SettingMRI-based assessment in a clinical radiology setting.

Key Highlights

  • Study included 108 patients with MRI-confirmed endolymphatic hydrops.
  • No significant associations found between EH severity and migraine biomarkers.
  • Left vestibular EH grade 1 linked to sudden hearing loss.
  • Left cochlear EH grade 1 linked to aural fullness.
  • Largest single-center EH cohort with comprehensive brain imaging assessment to date.

Guideline-Based Recommendations

Diagnosis

  • Incorporate MRI findings into the diagnosis of Menière’s disease.

Management

  • Avoid ineffective vestibular migraine treatments when severe unilateral EH confirms Menière’s disease.

Monitoring & Follow-up

  • Regular MRI assessments for patients with Menière’s disease to evaluate EH.

Risks

  • Potential misdiagnosis between vestibular migraine and Menière’s disease.

Patient & Prescribing Data

Patients with endolymphatic hydrops and potential migraine overlap.

Understanding the distinct imaging phenomena of EH and migraine may guide precision therapy.

Clinical Best Practices

  • Utilize high-resolution 3 T MRI for accurate visualization of endolymphatic hydrops.
  • Assess for migraine biomarkers in patients with EH to clarify diagnosis.

Related Resources & Content

Original Source(s)

Related Content